View graph of relations
  1. 2019
  2. Published
    Alzheimers Dis Neuroimaging Initia, van Maurik, I. S., Vos, S. J., Bos, I., Bouwman, F. H., Teunissen, C. E., ... van der Flier, W. M. (2019). Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurology, 18(11), 1034-1044. https://doi.org/10.1016/S1474-4422(19)30283-2
  3. Published
    Shi, L., Westwood, S., Baird, A. L., Winchester, L., Dobricic, V., Kilpert, F., ... Nevado-Holgado, A. J. (2019). Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimer's & Dementia, 15(11), 1478-1488. https://doi.org/10.1016/j.jalz.2019.06.4951
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published
    Alzheimer Dis Neuroimaging Initiat, AIBL Res Grp, ICTUS Study Grp, DSA Study Grp, Vermunt, L., Sikkes, S. A. M., ... Spiru, L. (2019). Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimer's & Dementia, 15(7), 888-898. https://doi.org/10.1016/j.jalz.2019.04.001
  10. Published
    Alzheimer's Dis Neuroimaging Initi, Vermunt, L., van Paasen, A. J. L., Teunissen, C. E., Scheltens, P., Visser, P. J., & Tijms, B. M. (2019). Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Neurology, 92(23), E2699-E2705. https://doi.org/10.1212/WNL.0000000000007609
  11. Published
    Lleo, A., Alcolea, D., Martinez-Lage, P., Scheltens, P., Parnetti, L., Poirier, J., ... Blennow, K. (2019). Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study. Alzheimer's & Dementia, 15(6), 742-753. https://doi.org/10.1016/j.jalz.2019.01.015
  12. Published
    MOPEAD Consortium, Rodriguez-Gomez, O., Rodrigo, A., Iradier, F., Santos-Santos, M. A., Hundemer, H., ... Boada, M. (2019). The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community. Alzheimer's & Dementia, 15(6), 828-839. https://doi.org/10.1016/j.jalz.2019.02.003
  13. Published
  14. Published
  15. Published
  16. Published
    Alzheimer's Dis euroimaging Initia, DESCRIPA Working Grp, Insight-PreAD Study Grp, SCD-I Working Grp, Slot, R. E. R., Sikkes, S. A. M., ... van der Flier, W. M. (2019). Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia. Alzheimer's & Dementia, 15(3), 465-476. https://doi.org/10.1016/j.jalz.2018.10.003
  17. Published
    ROADMAP Consortium, Gallacher, J., de Vulpillieres, F. D. R., Amzal, B., Angehrn, Z., Bexelius, C., ... Visser, P. J. (2019). Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project. Journal of Alzheimer's Disease, 67(2), 495-501. https://doi.org/10.3233/JAD-180370
  18. Published
  19. 2018
  20. Published
    Westwood, S., Baird, A. L., Hye, A., Ashton, N. J., Nevado-Holgado, A. J., Anand, S. N., ... Lovestone, S. (2018). Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result. Frontiers in Aging Neuroscience, 10, [409]. https://doi.org/10.3389/fnagi.2018.00409
  21. Published
    Alzheimer's Dis Neuroimaging, Amsterdam Dementia Cohort, ten Kate, M., Dicks, E., Visser, P. J., van der Flier, W. M., ... Tijms, B. M. (2018). Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline. Brain, 141, 3443-3456. https://doi.org/10.1093/brain/awy264
  22. Published
    Legdeur, N., Badissi, M., Carter, S. F., de Crom, S., van de Kreeke, A., Vreeswijk, R., ... Visser, P. J. (2018). Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+study. BMC Geriatrics, 18, [289]. https://doi.org/10.1186/s12877-018-0984-z
  23. Published
    Bergeron, D., Gorno-Tempini, M. L., Rabinovici, G. D., Santos-Santos, M. A., Seeley, W., Miller, B. L., ... Ossenkoppele, R. (2018). Prevalence of amyloid-beta pathology in distinct variants of primary progressive aphasia. Annals of Neurology, 84(5), 729-740. https://doi.org/10.1002/ana.25333
  24. Published
  25. Published
  26. Published
    ADNI, Tijms, B. M., Vermunt, L., Zwan, M. D., van Harten, A. C., van der Flier, W. M., ... Visser, P. J. (2018). Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals. Annals of Clinical and Translational Neurology, 5(9), 1037-1047. https://doi.org/10.1002/acn3.615
  27. Published
    Legdeur, N., Heymans, M. W., Comijs, H. C., Huisman, M., Maier, A. B., & Visser, P. J. (2018). Age dependency of risk factors for cognitive decline. BMC Geriatrics, 18, [187]. https://doi.org/10.1186/s12877-018-0876-2
  28. Published
    Konijnenberg, E., Carter, S. F., ten Kate, M., den Braber, A., Tomassen, J., Amadi, C., ... Visser, P. J. (2018). The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimer's Research & Therapy, 10, [75]. https://doi.org/10.1186/s13195-018-0406-7
  29. Published
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
    ten Kate, M., Sudre, C. H., den Braber, A., Konijnenberg, E., Nivard, M. G., Cardoso, M. J., ... Visser, P. J. (2018). White matter hyperintensities and vascular risk factors in monozygotic twins. Neurobiology of Aging, 66, 40-48. https://doi.org/10.1016/j.neurobiolaging.2018.02.002
  36. Published
  37. Published
    Insight-PreAD Study Grp, ten Kate, M., Visser, P. J., Bakardjian, H., Barkhof, F., Sikkes, S. A. M., ... Tijms, B. M. (2018). Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults. Frontiers in Aging Neuroscience, 10, [67]. https://doi.org/10.3389/fnagi.2018.00067
  38. Published
  39. Published
    Tijms, B. M., Willemse, E. A. J., Zwan, M. D., Mulder, S. D., Visser, P. J., van Berckel, B. N. M., ... Teunissen, C. E. (2018). Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-beta 1-42 Analysis Results. Clinical Chemistry, 64(3), 576-585. https://doi.org/10.1373/clinchem.2017.281055
  40. Published
  41. Published
  42. Published
  43. Published
  44. 2017
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published
  50. Published
    Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., ... Winblad, B. (2017). Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Lancet Neurology, 16(8), 661-676. https://doi.org/10.1016/S1474-4422(17)30159-X
  51. Published
    Bos, I., Vos, S. J., Froelich, L., Kornhuber, J., Wiltfang, J., Maier, W., ... Alzheimer's Dis Neuroimaging Initi (2017). The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. Neurobiology of Aging, 56, 33-40. https://doi.org/10.1016/j.neurobiolaging.2017.03.034
  52. Published
  53. Published
Previous 1 2 3 Next